Technology

ADA 2022: Primary care patients with T2D and HbA1c >7.5% achieved as much as a 1.5% drop in HbA1c after initiating real time continuous glucose monitoring.

ADA 2022: Patients with T2D who received a treatment intervention powered by artificial intelligence achieved a remission rate of more than 80%.

DiabetesWise Pro lets clinicians compare diabetes devices for a specific patient and provides the steps for ordering the device based on insurance type.

The Abbott FreeStyle Libre 3 is the smallest, thinnest, and most accurate 14-day CGM with a 7.9% MARD, the company says.

Lead author of a recent study discusses why clinicians may be hesitant to use TikTok and how social media may shape health care going forward.

Compare, contrast, price shop, prescribe. DiabetesWise Pro developer Korey Hood, PhD, highlights the tool all primary care clinicians should try.

Lead author of a recent study sat down with Patient Care to discuss how clinicians are using the popular video sharing app and the quality of content available.

The wearable device allows users to monitor their health while also performing their regular daily activities.

New study presented at Heart Rhythm 2022 showed applying AI to an Apple Watch ECG can effectively identify LV dysfunction in a nonclinical setting.

DiabetesWise Pro, created at Stanford University, provides an unbranded, unbiased guide to matching diabetes technology to patient needs, access, and lifestyle.